• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-

Return to search Page to restart search Return to Orphan Designation Search Page Return to Search Page
 
Generic Name:  5ÿ¿ÿÿÿ¢ÿ¿ÿÿ¬"-GAATATTAACAIACTGACAAGTC-3ÿ¿ÿÿÿ¢ÿ¿ÿÿ¬"
Trade Name:  n/a
Date Designated:  10/31/2012
Orphan Designation:  Prophylaxis following documented or suspected exposure to marburg virus
Orphan Designation Status:  Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Sarepta Therapeutics, Inc.
215 First Street
Suite 7
Cambridge, Maryland 02142

The sponsor address listed is the last reported by the sponsor to OOPD.

-
-